Home
Advertisement & Sponsorship Options
Download Our Media Kit
Changing Physician Behavior
Cancer A – Z
Drug Developmemt Technologies
A Novel Technology based on Somatic Hypermutation (SHM)
Editorial Advisory Board
Join Our Editorial Advisory Board
Contact Us
Terms and Conditions
Publications
SABCS and ASH 2023
ADC Review | J. Antibody-drug Conjugates
Resources for For Clinicians
Drug Map (ADC)
Peer Review Articles
The Review
Changing Strategies in the War on Cancer
Changing Strategies in the War on Cancer – Episode 1
Changing Strategies in the War on Cancer – Episode 2
Changing Strategies in the War on Cancer – Episode 3
Centers of the Cancer Universe: A Half-Century of Progress Against Cancer
Journal of CAR T-Cell Therapy
About CAR T-cells
Frequently Asked Questions
Types of Articles
Submit a Manuscript
The Onco’Zine Brief
The Network
The Episodes
How to Support The Onco’Zine Brief
Corporate Underwriting and Sponsorship
The Onco’Zine Dossier
Thalidomide: A History
Thalidomide: In the Shadow of Death
Controversy: The involvement of Ciba AG in the development of Thalidomide
Thalidomide’s Secret Past: The Link with Nazi Germany
Reversal of Fortune: How a Vilified Drug Became a Life-saving Agent in the ‘War’ Against Cancer
Smoking and Health
New Surgeon General’s Report Presents the Unfiltered Truth About Tobacco
Smoking and the Lost Legacy of the First Surgeon General’s Report on Smoking and Health
Tobacco Control in the United States Has Saved 8 Million Lives In Last 50 Years
Tobacco Companies are Finally Moving Closer to Revealing the Truth about Smoking
The Harmful Effects of Smoking: The Public Denial in the Early-mid 1960s
Drug Approvals 2017 – 2020
Oncology & Hematology – FDA Drug Approvals 2018
Oncology & Hematology – FDA Drug Approvals 2019
Oncology & Hematology – FDA Drug Approvals 2020
Articles
Latest Articles
Expert Interviews
Editorials and Commentaries
Eric Rosenthal Reports
Publications
News
Business & Economics
Clinical Development
Conference Coverage
The Onco’Zine Brief
The Episodes
National Advertising
Resources
Membership
Agenda
Join Today
Video
Careers
Search
About
Advertise
Advisory Board
Contact Us
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Onco'Zine
Advertisement #1
Home
Advertisement & Sponsorship Options
Download Our Media Kit
Changing Physician Behavior
Cancer A – Z
Drug Developmemt Technologies
A Novel Technology based on Somatic Hypermutation (SHM)
Editorial Advisory Board
Join Our Editorial Advisory Board
Contact Us
Terms and Conditions
Publications
SABCS and ASH 2023
ADC Review | J. Antibody-drug Conjugates
Resources for For Clinicians
Drug Map (ADC)
Peer Review Articles
The Review
Changing Strategies in the War on Cancer
Changing Strategies in the War on Cancer – Episode 1
Changing Strategies in the War on Cancer – Episode 2
Changing Strategies in the War on Cancer – Episode 3
Centers of the Cancer Universe: A Half-Century of Progress Against Cancer
Journal of CAR T-Cell Therapy
About CAR T-cells
Frequently Asked Questions
Types of Articles
Submit a Manuscript
The Onco’Zine Brief
The Network
The Episodes
How to Support The Onco’Zine Brief
Corporate Underwriting and Sponsorship
The Onco’Zine Dossier
Thalidomide: A History
Thalidomide: In the Shadow of Death
Controversy: The involvement of Ciba AG in the development of Thalidomide
Thalidomide’s Secret Past: The Link with Nazi Germany
Reversal of Fortune: How a Vilified Drug Became a Life-saving Agent in the ‘War’ Against Cancer
Smoking and Health
New Surgeon General’s Report Presents the Unfiltered Truth About Tobacco
Smoking and the Lost Legacy of the First Surgeon General’s Report on Smoking and Health
Tobacco Control in the United States Has Saved 8 Million Lives In Last 50 Years
Tobacco Companies are Finally Moving Closer to Revealing the Truth about Smoking
The Harmful Effects of Smoking: The Public Denial in the Early-mid 1960s
Drug Approvals 2017 – 2020
Oncology & Hematology – FDA Drug Approvals 2018
Oncology & Hematology – FDA Drug Approvals 2019
Oncology & Hematology – FDA Drug Approvals 2020
Articles
Latest Articles
Expert Interviews
Editorials and Commentaries
Eric Rosenthal Reports
Publications
News
Business & Economics
Clinical Development
Conference Coverage
The Onco’Zine Brief
The Episodes
National Advertising
Resources
Membership
Agenda
Join Today
Video
Careers
Home
Conference Coverage
AACR
AACR
Combination of Olaparib + Ceralasertib Offers Clinical Benefit in DNA Repair-deficient Tumors
Editorial Team
-
April 21, 2023
Sudocetaxel Zendusortide Shows Potential as a Single Agent and as a Combination Therapy
Study Shows Positive Initial Phase 1 Pharmacokinetic, Pharmacodynamic and Safety Data for IMM-1-104
How Whole Exome Sequencing Improves Identification of People With Cancer Predisposition Syndromes
Investigational Deep Learning Model may Accurately Predict Recurrence of Endometrial Cancer
Brain Metastases from Renal Cell Carcinoma May have Immune- suppressive Tumor Microenvironments
Editorial Team
-
April 18, 2023
Survey Shows Awareness of the Link Between Human Papillomavirus and Cervical Cancer Has Declined
Editorial Team
-
April 17, 2023
REGN5459 Shows Encouraging Clinical Activity in Patients With r/r Multiple Myeloma
Editorial Team
-
April 17, 2023
Genomic Basis of Racial Disparities in Colon Cancer Highlight Importance Ancestry Stratification
Editorial Team
-
April 17, 2023
L-MIND Study Shows Prolonged, Durable Responses in r/r DLBCL Patients Treated with Tafasitamab
Editorial Team
-
April 17, 2023
Patients with Rare Type of Skin Cancer May Benefit from Single-agent Pembrolizumab
Editorial Team
-
April 16, 2023
Novel Liquid Biopsy-based Test May Detect Early-stage Disease and Low DNA-shedding Cancers
Editorial Team
-
April 16, 2023
Keynote-966: Pembrolizumab + Chemotherapy May Benefit Patients with Advanced Biliary Tract Cancer
Editorial Team
-
April 16, 2023
AEGEAN Trial Shows a 32% Reduction in the Risk of Disease Recurrence or Progression...
Editorial Team
-
April 16, 2023
Adjuvant Atezolizumab and Bevacizumab May Delay Recurrence After Surgical Resection of Liver Cancer
Editorial Team
-
April 16, 2023
1
2
Page 1 of 2
LATEST NEWS
DNADX® Test Significantly Correlates with Patient Outcomes in Clinical Studies
Editorial Team
-
December 7, 2023
No differences Between Palbociclib-letrozole and Palbociclib-fulvestrant in HR+/HER2- advanced BC
Editorial Team
-
December 7, 2023
Drug Combination Shows Promise in Treatment of Nerve Sheath Tumors
Editorial Team
-
December 1, 2023
Genomic Nasal Swab Test may Improve Lung Cancer Risk Assessment for Smokers with Lung...
Editorial Team
-
November 30, 2023
Preoperative Intravenous Iron Reduces the Need for Blood Transfusion in Colorectal Cancer Surgery
Peter Hofland
-
November 25, 2023
X